Drugs / Triaxis
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT05856396 Comparator | Sep 2023 → Dec 2025 | pertussis | Centre Hospitalier Universitaire Saint Pierre | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Triaxis | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05856396 ↗ |
| Modality | Vaccine | “Triaxis® (Pertussis-containing vaccine)” NCT05856396 ↗ |